A hand-held, miniature microscope roughly the size of a pen can allow surgeons to "see" at a cellular level in the operating room and determine where to stop cutting the tumour to kill only cancerous cells and protect healthy cells.
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
A hand-held, miniature microscope roughly the size of a pen can allow surgeons to "see" at a cellular level in the operating room and determine where to stop cutting the tumour to kill only cancerous cells and protect healthy cells.
The Indian government will start promoting birth spacing by expanding choice of contraceptives and improving quality healthcare in the country, Health Minister J.P. Nadda said here on Monday.
British Chancellor George Osborne and Microsoft founder Bill Gates announced in Liverpool three billion pounds ($4.27 billion) in funding over the next five years for research and efforts to eliminate malaria.
India urgently needs to resolve issues pertaining to its healthcare sector in the light of the gross neglect the sector has witnessed over the years, experts have suggested.
Ten doctors at CHI Health Centre in the Omaha city of Nebraska state in the US are using Google Glass - personal assistant tool to help them take better care of patients by reducing the cumbersome paperwork.
British scientists have achieved a remarkable breakthrough in the transformation of human cells that paves the way for a new range of treatments for a variety of medical conditions.
India's universal health coverage policy needs to be extensive, considering the role of the states and Centre and lower than expected performance of healthcare services, experts opined here on Saturday at a conference on healthcare.
The controversial pesticide endosulfan, widely used by Indian farmers, not only induces male infertility but also exerts damage on the liver and lungs, says a team of researchers from the Indian Institute of Science (IISc) in Bengaluru who have obtained conclusive evidence from animal studies.
Teenagers as young as 16 are experiencing chronic fatigue syndrome (CFS), say researchers, adding that it shows that the condition is much more common in them than previously thought.
Agenus Inc., an immuno-oncology company developing checkpoint modulator antibodies and cancer vaccines, announced that the U.S. Food and Drug Administration (FDA) cleared the company's investigational new drug (IND) application for AGEN1884, an immune checkpoint modulator (CPM) antibody that binds to cytotoxic T-lymphocyte antigen-4 (CTLA-4). Clearance was also received for a second CPM antibody partnered with Incyte (NASDAQ: INCY) for INCAGN1876, which targets glucocorticoid-induced TNFR-related protein (GITR). Clinical trials for both candidates are expected to begin in the first half of 2016.